1
by Sherer, Todd
Published 2013
Henry Stewart Talks
Table of Contents: ...The need for disease-modifying therapies for Parkinson's disease -- Promising targets and pathways...

2
Published 2018
Humana
Table of Contents: ... that Target the Endocannabinoid Receptors in Huntington’s Disease -- Dissection and Preparation of Human...

3
by Barker, Roger A
Published 2007
Henry Stewart Talks
Table of Contents: ... -- New disease modifying therapies -- Neural transplants...

4
by Zawada, Edward T. Jr.
Published 2020
IntechOpen
...Renal diseases can be explosive and difficult to control or silent but progressive. Those...

5
by Fisher, Abraham, Hanin, Israel, Lachman, Chaim
Published 1987
Springer US
Table of Contents: ... -- Developing Institutional Policies to Obviate Agonizing Over Complex Ethical Dilemmas -- Alzheimer’s Disease...

6
Published 2001
Birkhäuser
Table of Contents: ... therapy for systemic vasculitis -- Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody...

7
by Masters, Colin L.
Published 2011
Henry Stewart Talks
Table of Contents: ...'s disease -- Compelling evidence for the Abeta theory of AD -- Delay onset of AD by 5 years -- The best...

8
Published 1988
Springer Berlin Heidelberg
Table of Contents: ... Motheaten” Mutant Mice -- A Molecular Genetic Approach to gld “Autoimmune” Disease -- Genetic Analysis...

9
Published 2016
Springer Basel
Table of Contents: ... in Inflammation -- TGF-b superfamily cytokine MIC-1/GDF15 in health and inflammatory diseases -- TNFalpha -- Type...

10
Published 2006
Springer US
Table of Contents: ...From the contents Genetic Factors Modifying Clinical Expression of Autosomal Dominant Rp -- Disease...

11
Published 2020
Springer International Publishing
Table of Contents: ...-rheumatic drugs in elderly -- Non Steroidal AntiInflammatory Drugs -- Synthetic Disease Modifying anti...

12
Published 2023
Springer International Publishing
...Huntington’s disease (HD) is a fatal, inherited, neurodegenerative disorder, characterized...

13
by Müller, Thomas
Published 2019
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...disease-modifying effects...

14
by Smith, Beth Paterson
Published 2010
Oregon Health & Science University
Subjects: ...Disease Progression...

15
by McDonagh, Marian S.
Published 2011
Oregon Health & Science University
Subjects: ...Disease Progression...

16
by Smith, Beth Paterson
Published 2010
Oregon Health & Science University
...There was no difference in relapse or disease progression between glatiramer and interferon beta-1a...

17
by McDonagh, Marian S.
Published 2011
Oregon Health & Science University
...PURPOSE: We compared the effectiveness and harms of fingolimod (Gilenya) to other disease-modifying...

18
by Klein, William L.
Published 2014
Henry Stewart Talks
Table of Contents: ...The oligomer cascade hypothesis for Alzheimer's Disease -- Why the oligomer hypothesis has largely...

19
by Veerle Baekelandt
Published 2015
Frontiers Media SA
...Understanding the molecular pathogenesis of Parkinson's disease (PD) is a priority in biomedical...

20
Published 2002
Humana
Table of Contents: .... Systemic Autoimmune Diseases -- 18 Treatment of Systemic Lupus Erythematosus -- 19 Treatment...